Besides HDAC inhibitors, demethylating agents such as 5-aza-2′-deoxycytidine also sensitize melanoma cells to gamma irradiation, significantly decreasing viability as compared to each treatment alone [143]. This evidence concerns the gene HDAC9 and melanoma.